Wockhardt has received tentative FDA approval for marketing a generic version of 20-mg, 40-mg, 60-mg and 80-mg capsules containing Ziprasidone hydrochloride, which is used in the treatment of bipolar disorders and schizophrenia.
Yahoo! Finance